/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Outstanding shares: 79,187,836
QUEBEC CITY, July 10, 2012 /CNW/ - CO2 Solutions Inc. (TSXV: CST), an innovator in the field of enzyme-enabled carbon capture technology, announced today the completion of the initial investigatory phase of its carbon capture pilot program with Alcoa, Inc. The project, started in April, 2011, is designed to capture and sequester industrial carbon emissions in alumina production waste, neutralize these materials and then create a commercially viable product.
The program, part of Alcoa's ongoing commitment to enhance its operational sustainability, proposed to use Alcoa's induct scrubber technology to capture carbon dioxide (CO2) emissions. After capturing the emissions, the technology treats and then uses a primary by-product of the aluminum manufacturing process known as alkaline clay, or bauxite residue, as well as other alkaline industrial residuals.
The initial stage of the project tested Alcoa's gas scrubbing process using enzymatic technology from CO2 Solutions and Codexis, Inc. Alcoa funded the project, which also received financial contributions from the U.S. Department of Energy (DOE), made available by the American Recovery and Reinvestment Act (ARRA).
The results of the initial phase of the project have been reviewed by CO2 Solutions, Codexis and Alcoa scientists and engineers. The project yielded positive results at bench scale, which confirmed the potential of the enzymatic technology for efficient CO2 capture from industrial effluent gases.
The following important, positive technical results were noted:
- The use of CO2 Solutions/Codexis technology provided for marked increases in CO2 capture efficiency and the ability to reduce equipment sizing
- Enzyme stability was noted in the carbonate solvent employed
- The potential to utilize enzymes to enhance CO2 capture with a carbonate solvent was confirmed and provides the opportunity to apply this technology approach to other industrial applications
The project could not meet the DOE project completion schedule, which called for full commercial deployment by 2014 and consequently will not move ahead to the next phase at this time. However, CO2 Solutions will continue with the further development of this application of its technology.
"While the project will not proceed as planned, the technical results validate our belief that our enzyme-enabled carbon capture technology will become commercially viable for both carbon dioxide capture and sequestration," said Glenn R. Kelly, CO2 Solutions' President and Chief Executive Officer. "The positive results from this program have already led to evaluations of our technology being undertaken with other industrial partners."
About CO2 Solutions Inc.
CO2 Solutions is an innovator in the field of enzyme-enabled carbon capture and has been actively working to develop and commercialize the technology for stationary sources of carbon pollution. CO2 Solutions' technology lowers the cost barrier to Carbon Capture, Sequestration and Utilization (CCSU), positioning it as a viable CO2 mitigation tool, as well as enabling industry to derive profitable new products from these emissions. CO2 Solutions has built an extensive patent portfolio covering the use of carbonic anhydrase, or analogues thereof, for the efficient post‐combustion capture of carbon dioxide with low‐energy aqueous solvents. Further information can be found at www.co2solutions.com
CO2 Solutions Forward-looking Statements
Certain statements in this news release may be forward-looking. These statements relate to future events or CO2 Solutions' future economic performance and reflect the current assumptions and expectations of management. Certain unknown factors may affect the events, economic performance and results of operations described herein. CO2 Solutions undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information:
Investor Relations and Media Contact:
416-815-0700, ext. 225